| COMPOSITION | |
|---|---|
| Esomeprazole | 40MG |
| Domperidone SR | 30MG |
Esomeprazole Domperidone SR
ESOVIB DSR
| SPECIFICATION | |
|---|---|
| FORM | CAPSULE |
| PACKING | 10×10 |
| PACKING TYPE | ALU ALU |
| MRP | 990 |
DESCRIPTION
A highly effective inhibitor of gastric acid secretion used in the therapy of stomach ulcers and zollinger-ellison syndrome. The drug inhibits the H(+)-K(+)-ATPase (H(+)-K(+)-exchanging ATPase) in the proton pump of gastric parietal cells. [PubChem]
A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms. [PubChem]
SIDE EFFECTS
Blurred vision, confusion, drowsiness, dry mouth, flushing headache, nausea, rapid heartbeat, sweating
Side effects include galactorrhea, gynecomastia, or menstrual irregularities.
INDICATION
For the treatment of acid-reflux disorders (GERD), peptic ulcer disease, H. pylori eradication, and prevention of gastroinetestinal bleeds with NSAID use.
For management of dyspepsia, heartburn, epigastric pain, nausea, and vomiting.